SV106 Human CD8 T cell Delivery Kit

We are proud to introduce a series of Ready-to-Use mRNA Delivery Kits, now officially ACRO Certify verified. This advanced portfolio originates from a pioneering biotechnology platform, which specializes in the development of next-generation lipid nanoparticle (LNP) delivery systems and self-amplifying mRNA (samRNA) platforms. Backed by an industry-leading proprietary library of over one million molecular structures and more than 60,000 high-throughput screened ionizable lipids, the underlying technology has successfully passed ACRO’s rigorous verification and performance certification.

The kit is designed for proof-of-concept studies and screening mRNA constructs ex vivo and in vivo.

For research use only.

• mRNA candidate screening
• In vitro transfection validation
• In vivo efficacy evaluation

• Streamline LNP production without microfluidics – simple mixing, immediate results.
• High encapsulation efficiency.
• High target specificity.

This product is stable in storage under the following conditions:

· Lipid Mixture: -70°C

· Formulation Buffer: Room Temperature

· Reagent A: -70°C

· Reagent B-4: 4°C

The lipid materials used in these ready-to-use tLNP kits are sourced from a certified proprietary library. For programs requiring further development, process support and flexible licensing arrangements are available to ensure continuity and regulatory compliance.